文献速递眼底病与葡萄膜炎

罕见补体因子H变异对阿米什人年龄相关性黄斑变性的影响

Consequences of a Rare Complement Factor H Variant for Age-Related Macular Degeneration in the Amish.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

本研究在1326名阿米什人中检测CFH P503A变异,新发现39名携带者,共58名。携带者与非携带者在AMD诊断年龄、CFH RNA和蛋白表达及CRP水平上均无显著差异,计算建模显示CFH蛋白构象轻微改变,作者假设该变异可能影响CFH结合或功能而非表达,需进一步研究确认。

要点

  • 在俄亥俄州和印第安纳州阿米什人中新发现39名CFH P503A携带者,共58名。
  • 携带者与非携带者AMD诊断年龄、CFH RNA和蛋白表达及CRP水平均无显著差异。
  • 计算建模显示CFH蛋白构象轻微改变,作者假设变异可能影响CFH结合或功能而非表达。

核心结论

  • 在俄亥俄州和印第安纳州阿米什人中总共发现58名CFH P503A风险等位基因携带者。
  • 携带者与非携带者在AMD诊断年龄及血样中CFH表达水平上未检测到显著差异,但通过计算机建模观察到CFH蛋白的轻微结构改变。
  • 基于功能与计算观察,作者假设CFH P503A可能影响CFH结合或功能而非表达,需进一步研究确认。

研究设计与样本

  • 对1326名阿米什人进行CFH P503A基因分型以识别更多风险等位基因携带者。
  • 比较携带者与非携带者AMD诊断年龄的差异。
  • 在携带者与非携带者血样中定量CFH RNA表达、CFH蛋白表达和C反应蛋白(CRP)表达。
  • 使用Phyre2和Chimera软件对CFH蛋白结构变化进行计算机模拟分析。

主要发现

  • 从俄亥俄州和印第安纳州阿米什社区新识别39名携带者,加上既往19名共58名风险等位基因携带者。
  • 携带者AMD诊断年龄平均较非携带者年轻,但差异无统计学显著性。
  • 阿米什携带者与非携带者血样中CFH转录本和蛋白水平均无显著差异。
  • 携带者与非携带者血浆样本中CRP水平相当。
  • 计算蛋白建模显示CFH蛋白构象轻微改变,预测会改变CFH 503残基与邻近残基的相互作用。

局限性

  • 作者假设CFH P503A可能影响CFH结合或功能而非表达,需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Genetic variants in the complement factor H gene (CFH) have been consistently implicated in age-related macular degeneration (AMD) risk. However, their functional effects are not fully characterized. We previously identified a rare, AMD-associated variant in CFH (P503A, rs570523689) in 19 Amish individuals, but its functional consequences were not investigated. METHODS: We performed genotyping for CFH P503A in 1326 Amish individuals to identify additional risk allele carriers. We examined differences for age at AMD diagnosis between carriers and noncarriers. In blood samples from risk allele carriers and noncarriers, we quantified (i) CFH RNA expression, (ii) CFH protein expression, and (iii) C-reactive protein (CRP) expression. Potential changes to the CFH protein structure were interrogated computationally with Phyre2 and Chimera software programs. RESULTS: We identified 39 additional carriers from Amish communities in Ohio and Indiana. On average, carriers were younger than noncarriers at AMD diagnosis, but this difference was not significant. CFH transcript and protein levels in blood samples from Amish carriers and noncarriers were also not significantly different. CRP levels were also comparable in plasma samples from carriers and noncarriers. Computational protein modeling showed slight changes in the CFH protein conformation that were predicted to alter interactions between the CFH 503 residue and other neighboring residues. CONCLUSIONS: In total, we have identified 58 risk allele carriers for CFH P503A in the Ohio and Indiana Amish. Although we did not detect significant differences in age at AMD diagnosis or expression levels of CFH in blood samples from carriers and noncarriers, we observed modest structural changes to the CFH protein through in silico modeling. Based on our functional and computational observations, we hypothesize that CFH P503A may affect CFH binding or function rather than expression, which would require additional research to confirm.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Waksmunski AR, Miskimen K, Song YE, et al. Consequences of a Rare Complement Factor H Variant for Age-Related Macular Degeneration in the Amish. Invest Ophthalmol Vis Sci. 2022. PMID: 35930268. doi:10.1167/iovs.63.9.8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。